SOVERINI, SIMONA
SOVERINI, SIMONA
DIMEC - DIPARTIMENTO DI SCIENZE MEDICHE E CHIRURGICHE
Docenti di ruolo di IIa fascia
Simona Soverini; SOVERINI S.; Soverini Simona; S. SOVERINI
Deep Molecular Response Rate in Chronic Phase Chronic Myeloid Leukemia: Eligibility to Discontinuation Related to Time to Response and Different Frontline TKI in the Experience of the Gimema Labnet CML National Network
2025 Breccia, M.; Cucci, R.; Marsili, G.; Castagnetti, F.; Galimberti, S.; Izzo, B.; Sorà, F.; Soverini, S.; Messina, M.; Piciocchi, A.; Bonifacio, M.; Cilloni, D.; Iurlo, A.; Martinelli, G.; Rosti, G.; Stagno, F.; Fazi, P.; Vignetti, M.; Pane, F.
Comparison between indolent systemic mastocytosis and clonal mast cell disease not meeting WHO diagnostic criteria: A nationwide multicenter retrospective analysis
2024 Sciumè, Mariarita; Serpenti, Fabio; Zanotti, Roberta; Bonadonna, Patrizia; Tanasi, Ilaria; Crosera, Lara; Elena, Chiara; Mannelli, Francesco; Crupi, Francesca; Papayannidis, Cristina; Sartor, Chiara; Soverini, Simona; Rondoni, Michela; Eller‐Vainicher, Cristina; Pravettoni, Valerio; Rivolta, Federica; Alberti Violetti, Silvia; Croci, Giorgio Alberto; Migliorini, Anna Chiara; Bolli, Niccolò; Giannarelli, Diana; Grifoni, Federica Irene
Parallel single-cell metabolic analysis and extracellular vesicle profiling reveal vulnerabilities with prognostic significance in acute myeloid leukemia
2024 Forte, D.; Pellegrino, R. M.; Falvo, P.; Garcia-Gonzalez, P.; Alabed, H. B. R.; Maltoni, F.; Lombardi, D.; Bruno, S.; Barone, M.; Pasini, F.; Fabbri, F.; Vannini, I.; Donati, B.; Cristiano, G.; Sartor, C.; Ronzoni, S.; Ciarrocchi, A.; Buratta, S.; Urbanelli, L.; Emiliani, C.; Soverini, S.; Catani, L.; Bertolini, F.; Argüello, R. J.; Cavo, M.; Curti, A.
Tracking Response and Resistance in Acute Myeloid Leukemia through Single-Cell DNA Sequencing Helps Uncover New Therapeutic Targets
2024 Bruno, S.; Borsi, E.; Patuelli, A.; Bandini, L.; Mancini, M.; Forte, D.; Nanni, J.; Barone, M.; Grassi, A.; Cristiano, G.; Venturi, C.; Robustelli, V.; Atzeni, G.; Mosca, C.; De Santis, S.; Monaldi, C.; Poletti, A.; Terragna, C.; Curti, A.; Cavo, M.; Soverini, S.; Ottaviani, E.
Unstable major molecular response as a trigger for next generation sequencing-based BCR::ABL1 mutation testing in chronic myeloid leukemia
2024 Benesova, A.; De Santis, S.; Polivkova, V.; Pecherkova, P.; Krizkova, J.; Suchankova, P.; Monaldi, C.; Klamova, H.; Srbova, D.; Zizkova, H.; Hochhaus, A.; Soverini, S.; Machova Polakova, K.
European LeukemiaNet laboratory recommendations for the diagnosis and management of chronic myeloid leukemia
2023 Cross N.C.P.; Ernst T.; Branford S.; Cayuela J.-M.; Deininger M.; Fabarius A.; Kim D.D.H.; Machova Polakova K.; Radich J.P.; Hehlmann R.; Hochhaus A.; Apperley J.F.; Soverini S.
Prognosis in Chronic Myeloid Leukemia: Baseline Factors, Dynamic Risk Assessment and Novel Insights
2023 Iezza M.; Cortesi S.; Ottaviani E.; Mancini M.; Venturi C.; Monaldi C.; De Santis S.; Testoni N.; Soverini S.; Rosti G.; Cavo M.; Castagnetti F.
Resistance mutations in CML and how we approach them
2023 Soverini S.
SETD2 non genomic loss of function in advanced systemic mastocytosis is mediated by an Aurora kinase A/MDM2 axis and can be therapeutically targeted
2023 Mancini M.; Monaldi C.; De Santis S.; Papayannidis C.; Rondoni M.; Sartor C.; Bruno S.; Pagano L.; Criscuolo M.; Zanotti R.; Bonifacio M.; Tosi P.; Arock M.; Valent P.; Cavo M.; Soverini S.
Single-Cell Metabolic Profiling Integrated with Extracellular Vesicle Analysis Reveals Novel Metabolic Vulnerabilities and Prognostic Biomarkers in Acute Myeloid Leukemia
2023 Forte, D; Maltoni, F; Bruno, S; Garcia-Gonzalez, P; Cristiano, G; Sartor, C; Soverini, S; Catani, L; Argüello, Rj; Cavo, M; Curti, A
CDC20 in and out of mitosis: a prognostic factor and therapeutic target in hematological malignancies
2022 Bruno S.; Ghelli Luserna di Rora A.; Napolitano R.; Soverini S.; Martinelli G.; Simonetti G.
CML-184 A Novel Droplet Digital PCR Strategy for Rapid and Sensitive Detection of BCR::ABL1 Kinase Domain Mutations Conferring Resistance to Second-Generation Tyrosine Kinase Inhibitors
2022 de Santis S.; Monaldi C.; Martelli M.; Mancini M.; Bruno S.; Castagnetti F.; Gugliotta G.; Polakova K.M.; Ernst T.; Maar D.; Corner A.; Cavo M.; Soverini S.
Combined Inhibition of Polo-like Kinase-1 and Wee1 as a New Therapeutic Strategy to Induce Apoptotic Cell Death in Neoplastic Mast Cells
2022 Mancini M.; Monaldi C.; De Santis S.; Rondoni M.; Papayannidis C.; Sartor C.; Curti A.; Bruno S.; Cavo M.; Soverini S.
Droplet digital PCR for the detection of second-generation tyrosine kinase inhibitor-resistant BCR::ABL1 kinase domain mutations in chronic myeloid leukemia
2022 Soverini, S.; De Santis, S.; Martelli, M.; Monaldi, C.; Castagnetti, F.; Gugliotta, G.; Papayannidis, C.; Mancini, M.; Bruno, S.; Venturi, C.; Machova Polakova, K.; Ernst, T.; Maar, D.; Corner, A.; Cavo, M.
MPN-182 Droplet Digital PCR for Non-Invasive Detection of the KIT D816V Mutation in the Peripheral Blood of Patients With Suspected Systemic Mastocytosis
2022 Monaldi C.; de Santis S.; Mancini M.; Papayannidis C.; Sartor C.; Rondoni M.; Bruno S.; Cavo M.; Soverini S.
Overcoming Resistance to Kinase Inhibitors: The Paradigm of Chronic Myeloid Leukemia
2022 De Santis, S.; Monaldi, C.; Mancini, M.; Bruno, S.; Cavo, M.; Soverini, S.
Polo-like kinase-1, Aurora kinase A and WEE1 kinase are promising druggable targets in CML cells displaying BCR::ABL1-independent resistance to tyrosine kinase inhibitors
2022 Mancini M.; De Santis S.; Monaldi C.; Castagnetti F.; Lonetti A.; Bruno S.; Dan E.; Sinigaglia B.; Rosti G.; Cavo M.; Gugliotta G.; Soverini S.
Questions concerning tyrosine kinase-inhibitor therapy and transplants in chronic phase chronic myeloid leukaemia
2022 Baccarani M.; Bonifazi F.; Soverini S.; Castagnetti F.; Gugliotta G.; Saber W.; Estrada-Merly N.; Rosti G.; Gale R.P.
Treatment-free remission in chronic myeloid leukemia patients treated front-line with nilotinib: 10-year followup of the GIMEMA CML 0307 study
2022 Gugliotta G.; Castagnetti F.; Breccia M.; Levato L.; Intermesoli T.; D'Adda M.; Salvucci M.; Stagno F.; Rege-Cambrin G.; Tiribelli M.; Martino B.; Bocchia M.; Cedrone M.; Trabacchi E.; Cavazzini F.; Porretto F.; Sora F.; Simula M.P.; Albano F.; Soverini S.; Foa R.; Pane F.; Cavo M.; Saglio G.; Baccarani M.; Rosti G.
Assessment of individual molecular response in chronic myeloid leukemia patients with atypical BCR-ABL1 fusion transcripts: recommendations by the EUTOS cooperative network
2021 Schafer, V.; White, H. E.; Gerrard, G.; Mobius, S.; Saussele, S.; Franke, G. -N.; Mahon, F. -X.; Talmaci, R.; Colomer, D.; Soverini, S.; Machova Polakova, K.; Cross, N. C. P.; Hochhaus, A.; Ernst, T.